RETEVMO
RETEVMO
Approved
DIN Number
02516926
Drug Class
Human
Market Date
Jan 21, 2022
Company
HC
loxo oncology inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02516926
AIG Number0162988002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EX22 SELPERCATINIB
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
SELPERCATINIBActive
Strength: 80 MG
Monograph: SELPERCATINIB